Increased risk of ischaemic heart disease after kidney donation

被引:13
作者
Haugen, Anders J. [1 ,2 ]
Hallan, Stein [3 ]
Langberg, Nina E. [1 ,2 ]
Dahle, Dag Olav [1 ]
Pihlstrom, Hege [1 ]
Birkeland, Kare, I [1 ,2 ]
Reisaeter, Anna, V [1 ]
Midtvedt, Karsten [1 ]
Hartmann, Anders [1 ]
Holdaas, Hallvard [1 ]
Mjoen, Geir [1 ]
机构
[1] Oslo Univ Hosp, Rikshosp, Dept Transplant Med, Oslo, Norway
[2] Univ Oslo, Fac Med, Oslo, Norway
[3] St Olavs Hosp, Dept Nephrol, Trondheim, Norway
关键词
cardiovascular disease; epidemiology; kidney donation; CARDIOVASCULAR-DISEASE; RENAL-FUNCTION; FOLLOW-UP; DONORS; HYPERTENSION; OUTCOMES; CONSEQUENCES; METAANALYSIS; NEPHRECTOMY; RATIONALE;
D O I
10.1093/ndt/gfab054
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background Previous reports suggest increased risk of hypertension and cardiovascular mortality after kidney donation. In this study we investigate the occurrence of ischaemic heart disease and cerebrovascular disease, diabetes and cancer in live kidney donors compared with healthy controls eligible for donation. Methods Different diagnoses were assessed in 1029 kidney donors and 16 084 controls. The diagnoses at follow-up were self-reported for the controls and registered by a physician for the donors. Stratified logistic regression was used to estimate associations with various disease outcomes, adjusted for gender, age at follow-up, smoking at baseline, body mass index at baseline, systolic blood pressure at baseline and time since the donation. Results The mean observation time was 11.3 years [standard deviation (SD) 8.1] for donors versus 16.4 years (SD 5.7) for controls. The age at follow-up was 56.1 years (SD 12.4) in donors versus 53.5 years (SD 11.1) in controls and 44% of donors were males versus 39.3% in the controls. At follow-up, 35 (3.5%) of the donors had been diagnosed with ischaemic heart disease versus 267 (1.7%) of the controls. The adjusted odds ratio for ischaemic heart disease was 1.64 (confidence interval 1.10-2.43; P = 0.01) in donors compared with controls. There were no significant differences for the risks of cerebrovascular disease, diabetes or cancer. Conclusions During long-term follow-up of kidney donors, we found an increased risk of ischaemic heart disease compared with healthy controls. This information may be important in the follow-up and selection process of living kidney donors.
引用
收藏
页码:928 / 936
页数:9
相关论文
共 41 条
  • [1] Effects of Reduced Kidney Function Because of Living Kidney Donation on Left Ventricular Mass
    Altmann, Ursula
    Boeger, Carsten A.
    Farkas, Stefan
    Mack, Matthias
    Luchner, Andreas
    Hamer, Okka W.
    Zeman, Florian
    Debl, Kurt
    Fellner, Claudia
    Jungbauer, Carsten
    Banas, Bernhard
    Buchner, Stefan
    [J]. HYPERTENSION, 2017, 69 (02) : 297 - +
  • [2] Meta-analysis: Risk for hypertension in living kidney donors
    Boudville, Neil
    Prasad, G. V. Ramesh
    Knoll, Greg
    Muirhead, Norman
    Thiessen-Philbrook, Heather
    Yang, Robert C.
    Rosas-Arellano, M. Patricia
    Housawi, Abdulrahman
    Garg, Amit X.
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 145 (03) : 185 - 196
  • [3] Risk factors, confounding, and the illusion of statistical control
    Christenfeld, NJS
    Sloan, RP
    Carroll, D
    Greenland, S
    [J]. PSYCHOSOMATIC MEDICINE, 2004, 66 (06): : 868 - 875
  • [4] DAlmeida P, 1996, TRANSPLANT P, V28, P93
  • [5] Medical Outcomes in African American Live Kidney Donors: A Matched Cohort Study
    Doshi, M. D.
    Goggins, M. O.
    Li, L.
    Garg, A. X.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (01) : 111 - 118
  • [6] Post-nephrectomy development of renal function in living kidney donors: a cross-sectional retrospective study
    Fehrman-Ekholm, Ingela
    Kvarnstrom, Niclas
    Softeland, John M.
    Lennerling, Annette
    Rizell, Magnus
    Oden, Anders
    Simonsson, Tomas
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (07) : 2377 - 2381
  • [7] Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression
    Garg, A. X.
    Muirhead, N.
    Knoll, G.
    Yang, R. C.
    Prasad, G. V. R.
    Thiessen-Philbrook, H.
    Rosas-Arellano, M. P.
    Housawi, A.
    Boudville, N.
    [J]. KIDNEY INTERNATIONAL, 2006, 70 (10) : 1801 - 1810
  • [8] Cardiovascular disease and hypertension risk in living kidney donors: An analysis of health administrative data in Ontario, Canada
    Garg, Amit X.
    Prasad, G. V. Ramesh
    Thiessen-Philbrook, Heather R.
    Ping, Li
    Melo, Magda
    Gibney, Eric M.
    Knoll, Greg
    Karpinski, Martin
    Parikh, Chirag R.
    Gill, John
    Storsley, Leroy
    Vlasschaert, Meghan
    Mamdani, Muhammad
    [J]. TRANSPLANTATION, 2008, 86 (03) : 399 - 406
  • [9] Cardiovascular disease in kidney donors: matched cohort study
    Garg, Amit X.
    Meirambayeva, Aizhan
    Huang, Anjie
    Kim, Joseph
    Prasad, G. V. Ramesh
    Knoll, Greg
    Boudville, Neil
    Lok, Charmaine
    McFarlane, Philip
    Karpinski, Martin
    Storsley, Leroy
    Klarenbach, Scott
    Lam, Ngan
    Thomas, Sonia M.
    Dipchand, Christine
    Reese, Peter
    Doshi, Mona
    Gibney, Eric
    Taub, Ken
    Young, Ann
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 344 : 18
  • [10] Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals
    Gerstein, HC
    Mann, JFE
    Yi, QL
    Zinman, B
    Dinneen, SF
    Hoogwerf, B
    Hallé, JP
    Young, J
    Rashkow, A
    Joyce, C
    Nawaz, S
    Yusuf, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (04): : 421 - 426